Theralase Technologies Inc. V.TLT

TLT updated the corporate presentation Feb 7 2022

[DJDawg]

I'm sure there are some details in there that represent updates. They include BDT aproval in later 2022 which is interesting. Suggests may not be an imminent announcement but also suggests a high degree of confidence.

https://theralase.com/wp-content/uploads/2022/02/Corporate-PPT-020722.pdf

[enriquesuave]

The 90 day data seems the same as last Q report.  So probably they are waiting for more results at end of month? For next Quarterly?   Interesting bit on NSCLC .. "Rutherrin® + X-Ray Activation leads to a 3 log kill of human NSCLC cells in-vitro" A 3 log kill is 99.9% Tumor cell kill.  A Tumor with 10^9 cells( a Billion cells) is reduced to 10^6 ( a million cells.

[Yajne]

Thanks for 'heads up' on new Corporate deck. Very slick IMO. In the old days (pre-retirement) I would associate a presentation update with the company preparing to do a 'road show' for investors  Not sure if that is still the main reason these days, I guess we will soon see.

[enriquesuave]

Commercialization Phase January 2023 to December 2025 (Projected) Perhaps they are leaving the door open for Accelerated Approval as early as January 2023? Or up until 2025 for full Standard Approval?

[99942Apophis]

Yajne wrote Thanks for 'heads up' on new Corporate deck. Very slick IMO. In the old days (pre-retirement) I would associate a presentation update with the company preparing to do a 'road show' for investors  Not sure if that is still the main reason these days, I guess we will soon see. Normally I would agree with your reasoning Yajne!  Would you also consider the

[Yajne]

I hope you're right 99942A, I loaded up with a few more (20K) about 10 days ago expecting an earlier BTD then they're showing in new Corp deck. I'm hoping Vera has brought a new attitude of 'under promise' 'over deliever' and the dates in new presentation are very conservative.